Orris

Multiphasic Screening

Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
I now have comprehensive material. Here is a thorough answer on multiphasic screening.

Multiphasic Screening

Definition

Multiphasic screening is defined as the application of two or more screening tests in combination to a large number of people at one time, rather than carrying out separate tests for single diseases. The procedure may include:
  • A health questionnaire
  • Clinical examination
  • A range of measurements and investigations:
    • Chemical and haematological tests on blood and urine
    • Lung function assessment (spirometry)
    • Audiometry
    • Measurement of visual acuity
All of these can be performed rapidly with appropriate staffing, organization, and equipment.
  • Park's Textbook of Preventive and Social Medicine, p. 156

Context: Types of Screening

Multiphasic screening is one of three recognized types of screening:
TypeDescription
Mass screeningScreening of an entire population or sub-group, offered to all irrespective of individual risk (e.g., TB screening)
High-risk / Selective screeningApplied selectively to high-risk groups defined by epidemiological research; most productive use of resources (e.g., cervical cancer screening in lower socioeconomic groups)
Multiphasic screeningMultiple tests applied simultaneously to detect several diseases at once

Advantages (Theoretical Rationale)

  • Efficient use of resources - several diseases can be investigated in a single visit
  • Convenience for the patient - multiple tests at one session
  • Potentially detects previously unrecognized coexisting conditions
  • Provides a broad health profile of the individual

Disadvantages and Evidence Against

Evidence from randomized controlled studies in the UK and USA has raised serious doubts:
  1. No mortality/morbidity benefit: RCT evidence showed multiphasic screening did not demonstrate any benefit to the population in terms of reducing mortality or morbidity.
  2. Increased healthcare costs without observable benefit.
  3. Lack of test validation: Most tests used in multiphasic screening programs, as currently practised, have not been validated.
  4. South-East London Study: A randomized controlled trial evaluating multiphasic screening led to the withholding of further support for the programme based on negative findings.
  5. Statistical problem: When multiple independent tests are applied simultaneously, the probability of at least one false-positive rises substantially. If a single test has 95% specificity, applying 20 tests gives an expected false-positive rate close to 64% (1 - 0.95^20).
  • Park's Textbook of Preventive and Social Medicine, pp. 156, 686, 1131-1134

Criteria for a Worthwhile Screening Programme

Before initiating any screening (including multiphasic), both the disease and the test must meet specific criteria:

Disease Criteria

  1. Should be an important health problem (generally, high prevalence)
  2. Must have a recognizable latent or early asymptomatic stage
  3. Natural history (including latent-to-declared progression) must be adequately understood
  4. A test must exist that detects disease before signs/symptoms appear
  5. Facilities for confirming the diagnosis must be available
  6. An effective treatment must exist
  7. An agreed policy on who to treat (e.g., borderline cases) must be in place
  8. Good evidence that early detection and treatment reduces morbidity and mortality
  9. Expected benefits must exceed the risks and costs

Screening Test Criteria

The test must satisfy:
  • Acceptability - must be acceptable to the target population (non-painful, non-embarrassing)
  • Repeatability (Reliability) - consistent results on repeat testing; affected by observer variation, biological variation, and instrument errors
  • Validity - ability to correctly identify those with and without disease, measured by:
    • Sensitivity - ability to detect true positives
    • Specificity - ability to correctly identify true negatives
  • Yield - number of previously unrecognized cases identified
  • Simplicity, safety, rapidity, ease of administration, and cost

Key Distinction: Screening vs. Case-Finding vs. Diagnosis

TermDefinitionExample
ScreeningTesting asymptomatic populations not seeking careNeonatal screening, blood donor HIV serology
Case-findingTests for disease in patients seeking care for other reasonsVDRL in pregnant women
Diagnostic testsConfirmatory tests in patients with signs/symptomsEndocervical culture for gonorrhoea

Uses of Screening (Four Main Uses)

  1. Case detection (prescriptive screening) - presumptive identification of unrecognized disease for the patient's own benefit (e.g., PKU, neonatal screening)
  2. Control of disease - to limit spread (e.g., infectious disease contact tracing)
  3. Research purposes - studying natural history; initial screening = prevalence; subsequent = incidence
  4. Educational opportunities - creating public awareness and educating health professionals

Bottom Line

Multiphasic screening, while conceptually attractive as an efficient way to detect multiple diseases simultaneously, has been largely discredited by RCT evidence as failing to reduce population morbidity and mortality while increasing healthcare costs. Its key weaknesses are the lack of test validation and the statistical inevitability of high false-positive rates when multiple tests are combined. Selective (high-risk) screening, targeting populations most likely to benefit, is considered a more productive and resource-efficient approach.
  • Park's Textbook of Preventive and Social Medicine, pp. 155-157
This is a shared conversation. Sign in to Orris to start your own chat.